Recent Advances in the Synthesis of Quinoxalines. A Mini Review

References

• Kleemann, J. Engel, B. Kutscher, and D. Reichert, Pharmaceutical Substances: Synthesis, Patents, Applications, 5th ed. (Stuttgart: Thieme, 2008).
   Google Scholar
• E. Vicente, L. M. Lima, E. Bongard, S. Charnaud, R. Villar, B. Solano, A. Burguete, S. Perez-Silanes, I. Aldana, L. Vivas, et al, “Synthesis and Structure-Activity Relationship of 3-Phenylquinoxaline1,4-Di-N-Oxide Derivatives as Antimalarial Agents,” European Journal of Medicinal Chemistry 43, no. 9 (2008): 1903–10.
   PubMed Web of Science ®Google Scholar
• (a) C. O. Knowles, “Chemistry and Toxicology of Quinoxaline, Organotin, Organofluorine, and Formamidineacaricides,” Environmental Health Perspectives 14 (1976): 93–102.
   PubMed Web of Science ®Google Scholar
  (b) T. P. Selby, L. R. Denes, J. L. Kilama, and B. K. Smith, “Aryl-Substituted Quinoxalines and Related Heteroarenes as Novel Herbicides Prepared via Palladium-Catalyzed Cross-Coupling Methods,” ACS Symposium Series 584 (1995): 171–85.
   Google Scholar
  (c) G. Sakata, K. Makino, and Y. Kurasawa, “Recent Progress in the Quinoline Chemistry. Synthesis and Biological Activity,” Heterocycles 27 (1988): 2481–515. doi:10.1289/ehp.761493
   Web of Science ®Google Scholar
• (a) I. Saito and T. Matsuura, “Chemical Studies on Riboflavin and Related Compounds. I. Oxidation of Quinoxaline-2,3-Diols as a Possible Model for the Biological Decomposition of Riboflavin,” Biochemistry 6, no. 11 (1967): 3602–8.
   PubMed Web of Science ®Google Scholar
  (b) B. Y. Yan, Y. G. Xia, Q. H. Wang, D. Q. Dou, and H. X. Kuang, “Two New Amide Alkaloids from the Flower of Datura metel L. Chemistry and Mechanism of Action,” Environ 74 (1974): 625–52.
   Google Scholar
  (c) J. Azuaje, A. E. Maatougui, X. Garcia-Mera, and E. Sotelo, “Ugi-Based Approaches to Quinoxaline Libraries,” ACS Combinatorial Science 16 (2014): 403–11.
   PubMed Web of Science ®Google Scholar
  (d) M. Sato, T. Nakazawa, Y. Tsunematsu, K. Hotta, and K. Watanabe, “Echinomycin Biosynthesis,” Current Opinion in Chemical Biology 17 (2013): 537–45.
   PubMed Web of Science ®Google Scholar
• (a) M. E. Welsch, S. A. Snyder, and B. R. Strockwell, “Privileged Scaffolds for Library Design and Drug Discovery,” Current Opinion in Chemical Biology 14 (2010): 347–61.
   PubMed Web of Science ®Google Scholar
  (b) L. Constantino, and D. Barolocco, “Privileged Structures as Leads in Medicinal Chemistry,” Current Medicinal Chemistry 13 (2006): 65–85.
   PubMed Web of Science ®Google Scholar
• (a) A. K. Patra, S. Dhar, M. Nethaji, and A. R. Chakravarty, “Metal Assisted Red Light-Induced DNA Cleavage by Ternary L-Methionine Copper(II) Complexes of Planar Heterocyclic Bases,” Dalton Transactions 39 (2005): 896–902.
   Google Scholar
  (b) N. D. Sonawane and D. W. Rangnekar, “Synthesis and Reactions of 2-Amino-6-(3-Methyl-5-Oxo-1-Phenyl-2-Pyrazolin-4-yl)-4-Phenylpyridine-3-Carbonitrile,” Journal of Heterocyclic Chemistry 39 (2002): 303–8.
   Web of Science ®Google Scholar
• (a) A. E. A. Porter, in Comprehensive Heterocyclic Chemistry, edited by A. R. Katritzky and C. W. Rees (Oxford: Pergamon, 1984), 157–97.
   Google Scholar
  (b) G. H. Woo, J. K. Snyder, Z. K. Wan, “Sixmembered Ring Systems: Diazines and Benzo Derivatives,” Progress in Heterocyclic Chemistry 14 (2002): 279–309.
   Google Scholar
  (c) V. A. Mamedov and N. A. Zhukova, “Progress in Quinoxaline Synthesis,” Progress in Heterocyclic Chemistry 24 (2012): 55–88.
   Google Scholar
  (d) V. A. Mamedov and N. A. Zhukova, “Progress in Quinoxaline Synthesis,” Progress in Heterocyclic Chemistry 25 (2013): 1–45.
   Google Scholar
• (a) R. E. Dolle, B. Le Bourdonnec, A. J. Goodman, G. A. Morales, J. M. Salvino, and W. Zhang, “Comprehensive Survey of Chemical Libraries for Drug Discovery and Chemical Biology: 2006,” Journal of Combinatorial Chemistry 9, no. 6 (2007): 855–902.
   PubMedGoogle Scholar
  (b) R. E. Dolle, B. Le Bourdonnec, A. J. Goodman, G. A. Morales, C. J. Thomas, and W. Zhang, “Comprehensive Survey of Chemical Libraries for Drug Discovery and Chemical Biology: 2007,” Journal of Combinatorial Chemistry 10 (2008): 753–802.
   PubMedGoogle Scholar
  (c) R. E. Dolle, B. Le Bourdonnec, A. J. Goodman, G. A. Morales, C. J. Thomas, and W. Zhang, “Comprehensive Survey of Chemical Libraries for Drug Discovery and Chemical Biology: 2008,” Journal of Combinatorial Chemistry 11 (2009): 739–90.
   PubMed Web of Science ®Google Scholar
  (d) R. E. Dolle, B. Le Bourdonnec, K. Worm, G. A. Morales, C. J. Thomas, and W. Zhang, “Comprehensive Survey of Chemical Libraries for Drug Discovery and Chemical Biology: 2009,” Journal of Combinatorial Chemistry 12 (2010): 765–806.
   PubMedGoogle Scholar
• D. J. Brown, “Quinoxalines,” In The Chemistry of Heterocyclic Compounds, edited by E. C. Taylor, P. Wipf (Hoboken, NJ: John Wiley & Sons, 2004), 1–510.
   Google Scholar
• O. Hinsberg, “Ueberchinoxaline,” Berichte Der Deutschen Chemischen Gesellschaft 17 (1884): 318–23.
   Google Scholar
• D. F. Saifina and V. A. Mamedov, “New and Modified Classical Methods for the Synthesis of Quinoxalines,” Russian Chemical Reviews 79 (2010): 351–70.
   Web of Science ®Google Scholar
• (a) M. J. Haddadin and C. H. Issidorides, “Application of Benzofurazan Oxide to the Synthesis of Heteroaromatic N-Oxides,” Heterocycles 4 (1976): 767–816.
   Web of Science ®Google Scholar
  (b) M. J. Haddadin and C. H. Issidorides, “Enamines with Isobenzofuroxan: A Novel Synthesis of Quinoxaline-Di-N-Oxides,” Tetrahedron Letters 6 (1965): 3253–6.
   Google Scholar
  (c) C. H. Issidorides and M. J. Haddadin, “Benzofurazan Oxide. Reactions with Enolate Anions,” The Journal of Organic Chemistry 31 (1966): 4067–8.
   Web of Science ®Google Scholar
• M. N. Noolvi, H. M. Patel, V. Bhardwaj, and A. Chauhan, “Synthesis and In Vitro Antitumor Activity of Substituted Quinazoline and Quinoxaline Derivatives: Search for Anticancer Agent,” European Journal of Medicinal Chemistry 46, no. 6 (2011): 2327–46. doi:10.1016/j.ejmech.2011.03.015
   PubMed Web of Science ®Google Scholar
• A. Dell, D. H. Williams, H. R. Morris, G. A. Smith, J. Feeney, and G. C. K. Roberts, “Structure Revision of the Antibiotic Echinomycin,” Journal of the American Chemical Society 97, no. 9 (1975): 2497–502.
   PubMed Web of Science ®Google Scholar
• D. Obrien, M. Weaver, D. Lidzey, and D. Bradley, “Use of Poly (Phenyl Quinoxaline) as an Electron Transport Material in Polymer Light-Emitting Diodes,” Applied Physics Letters 69 (1996): 881–3.
   Web of Science ®Google Scholar
• K. R. J. Thomas, M. Velusamy, J. T. Lin, C. H. Chuen, and Y. T. Tao, “Chromophore-Labeledquinoxaline Derivatives as Efficient Electroluminescent Materials,” Chemistry of Materials 17 (2005): 1860–6.
   Web of Science ®Google Scholar
• S. Dailey, W. J. Feast, R. J. Peace, I. C. Sage, S. Till, and E. L. Wood, “Synthesis and Device Characterisation of Side-Chain Polymer Electron Transport Materials for Organic Semiconductor Applications,” Journal of Materials Chemistry 11 (2001): 2238–43.
   Web of Science ®Google Scholar
• M. Zhang, Z. C. Dai, S. S. Qian, J. J. Liu, Y. Xiao, A. M. Lu, H. L. Zhu, J. X. Wang, and Y. H. Ye, “Design, Synthesis, Antifungal, and Antioxidant Activities of (E)-6-((2-Phenylhydrazono)Methyl)Quinoxaline Derivatives,” Journal of Agricultural and Food Chemistry 62, no. 40 (2014): 9637–43.
   PubMed Web of Science ®Google Scholar
• Y. B. Wang, L. Shi, X. Zhang, L. R. Fu, W. Hu, W. Zhang, X. Zhu, X. Hao, and M. P. Song, “NaOH-Mediated Direct Synthesis of Quinoxalines from o-Nitroanilines and Alcohols via a Hydrogen-Transfer Strategy,” The Journal of Organic Chemistry 86, no. 1 (2021): 947–58. doi:10.1021/acs.joc.0c02453
   PubMed Web of Science ®Google Scholar
• C. C. Tran, S. Kawaguchi, F. Sato, A. Nomoto, and A. Ogawa, “Photoinduced Cyclizations of o-Diisocyanoarenes with Organic Diselenides and Thiols That Afford Chalcogenated Quinoxalines,” The Journal of Organic Chemistry 85, no. 11 (2020): 7258–66.
   PubMed Web of Science ®Google Scholar
• J. Wu, H. Zhang, X. Ding, X. Tan, J. Chen, W. He, H. Deng, L. Song, H. C. Shen, and W. Cao, “Potassium Iodide-Promoted One-Pot Synthesis of Fluoroalkylated Quinoxalines via a Tandem Michael Addition/Azidation/Cycloamination Approach,” The Journal of Organic Chemistry 83, no. 16 (2018): 9422–9.
   PubMed Web of Science ®Google Scholar
• Y. Liu, X. Chen, F. Zeng, K. Sun, L. Fan C.Qu, Z. An, R. Li, C. Jing, S. Wei, L. Qu, et al, “Phosphorus Radical-Initiated Cascade Reaction to Access 2-Phosphoryl-Substituted,” The Journal of Organic Chemistry 83, no. 19 (2018): 11727–35.
   PubMed Web of Science ®Google Scholar
• C. Xie, Z. Zhang, D. Li, J. Gong, X. Han, X. Liu, and C. Ma, “Dimethyl Sulfoxide Involved One-Pot Synthesis of Quinoxaline Derivatives,” The Journal of Organic Chemistry 82, no. 7 (2017): 3491–9.
   PubMed Web of Science ®Google Scholar
• X. Lu, Q. Feng, T. Lan, G. Zhou, and Z. Wang, “Molecular Engineering of Quinoxaline-Based Organic Sensitizers for Highly Efficient and Stable Dye-Sensitized Solar Cells,” Chemistry of Materials 24, no. 16 (2012): 3179–87.
   Web of Science ®Google Scholar
• X. Han, T. Lei, X. Yang, L. Zhao, B. Chen, C. Tung, and L. Wu, “Aerobic Oxidation of β -Dicarbonyls into Vicinal Tricarbonyls by Cu(II) Salts for One-Pot Synthesis of Quinoxalines,” Tetrahedron Letters 58 (2017): 1770–4.
   Web of Science ®Google Scholar
• S. Chun, J. Ahn, P. Ramachandra Reddy, S. B. Lee, D. Oh, and S. Hong, “Direct Synthesis of Pyrrolo[1,2-α]Quinoxalines via Iron-Catalyzed Transfer Hydrogenation between 1-(2-Nitrophenyl)Pyrroles and Alcohols,” The Journal of Organic Chemistry 85, no. 23 (2020): 15314–24.
   PubMed Web of Science ®Google Scholar
• H. Ma, D. Li, and W. Yu, “Synthesis of Quinoxaline Derivatives via Tandem Oxidative. Azidation/Cyclization Reaction of N-Arylenamines,” Organic Letters 18, no. 4 (2016): 868–71.
   PubMed Web of Science ®Google Scholar
• J. Ahn, S. B. Lee, I. Song, S. Chun, D. Oh, and S. Hong, “Synthesis of 4-Aryl Pyrrolo[1,2-α]Quinoxalines via Iron-Catalyzed Oxidative Coupling from an Unactivated Methyl Arene,” The Journal of Organic Chemistry 86, no. 11 (2021): 7390–402.
   PubMed Web of Science ®Google Scholar
• H. Chen, Y. Chen, C. Liu, Y. Chien, S. Chou, and P. Chou, “ Prominent Short-Circuit Currents of Fluorinated Quinoxaline-Based Copolymer Solar Cells with a Power Conversion Efficiency of 8.0%,” Chemistry of Materials 24, no. 24 (2012): 4766–72.
   Web of Science ®Google Scholar
• H. Xu, and L. Fan, “Synthesis and Antifungal Activities of Novel 5,6-Dihydro-Indolo[1,2-a]Quinoxaline Derivatives,” European Journal of Medicinal Chemistry 46, no. 5 (2011): 1919–25.
   PubMed Web of Science ®Google Scholar
• N. Primas, P. Suzanne, P. Verhaeghe, S. Hutter, C. Kieffer, M. Laget, A. Cohen, J. Broggi, J. Lancelot, A. Lesnard, et al, “Synthesis and In Vitro Evaluation of 4-Trichloromethylpyrrolo[1,2-a] Quinoxalines as New Antiplasmodial Agents,” European Journal of Medicinal Chemistry 83 (2014): 26–35.
   PubMed Web of Science ®Google Scholar
• J. Li, J. Zhang, H. Yang, Z. Gao, and G. Jiang, “A Green Aerobic Oxidative Synthesis of Pyrrolo[1,2-a]Quinoxalines from Simple Alcohols without Metals and Additives,” The Journal of Organic Chemistry 82, no. 1 (2017): 765–9.
   PubMed Web of Science ®Google Scholar
• J. Qi, H. Dong, J. Huang, S. Zhang, L. Niu, Y. Zhang, and J. Wang, “Synthesis and Biological Evaluation of N-Substituted 3-Oxo-1,2,3,4-Tetrahydro-Quinoxaline-6-Carboxylic Acid Derivatives as Tubulin Polymerization Inhibitors,” European Journal of Medicinal Chemistry 143 (2018): 8–20.
   PubMed Web of Science ®Google Scholar
• Y. Yuan, Z. Wang, R. Yang, T. Qian, and Q. Zhou, “Naphthyl Quinoxaline Thymidine Conjugate is a Potent Anticancer Agent Post UVA Activation and Elicits Marked Inhibition of Tumor Growth through Vaccination,” European Journal of Medicinal Chemistry 171 (2019): 255–64.
   PubMed Web of Science ®Google Scholar
• D. Sarma, B. Majumdar, B. Deori, S. Jain, and T. K. Sarma, “Photoinduced Enhanced Decomposition of TBHP: A Convenient and Greener Pathway for Aqueous Domino Synthesis of Quinazolinones and Quinoxalines,” ACS Omega 6, no. 18 (2021): 11902–10.
   PubMed Web of Science ®Google Scholar
• S. D. Pardeshi, B. N. Patil, P. Patil, and A. C. Chaskar, “A Highly Divergent Pictet-Spengler Approach for Pyrrolo[1,2-a]Quinoxalines from Aryl Amine Using 1,2-Dinitrobenzene as an Oxidant,” Tetrahedron Letters 60 (2019): 151250.
   Web of Science ®Google Scholar
• B. Saha, B. Mitra, D. Brahmin, B. Sinha, and P. Ghosh, “2-Iodo Benzoic Acid: An Unconventional Precursor for the One Pot Multi-Component Synthesis of Quinoxaline Using Organo Cu (II) Catalyst,” Tetrahedron Letters 59 (2018): 3657–63.
   Web of Science ®Google Scholar
• J. M. Park, C. Y. Jung, J. H. Cho, D. H. Kim, Y. Wang, and J. Y. Jaung, “Synthesis of New di-Anchoring Organic Sensitizer Based on Quinoxaline Acceptor for Dye-Sensitized Solar Cells,” Tetrahedron Letters 59 (2018): 3322–5.
   Web of Science ®Google Scholar
• C. F. Gers, J. Nordmann, C. Kumru, W. Frank, and T. J. J. Muller, “Solvatochromic Fluorescent 2‑Substituted 3‑Ethynyl Quinoxalines: Four-Component Synthesis,” The Journal of Organic Chemistry 79, no. 8 (2014): 3296–310.
   PubMed Web of Science ®Google Scholar
• J. Guillon, M. Le Borgne, C. Rimbault, S. Moreau, S. Savrimoutou, N. Pinaud, S. Baratin, M. Marchivie, S. Roche, A. Bollacke, et al, "Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2," European Journal of Medicinal Chemistry 65C (2013): 205–22.
   Google Scholar
• B. Oyallon, M. Brachet-Botineau, C. Loge, P. Bonnet, M. Souab, T. Robert, S. Ruchaud, S. Bach, P. Berthelot, F. Gouilleux, et al, “Structure-Based Design of Novel Quinoxaline-2-Carboxylic Acids and Analogues as Pim-1 Inhibitors,” European Journal of Medicinal Chemistry 154 (2018): 101–9.
   PubMed Web of Science ®Google Scholar
• Q. Liu, K. Lu, H. Zhu, S. Kong, J. Yuan, G. Zhang, N. Chen, C. Gu, C. Pan, D. Mo, et al, “Identification of 3-(Benzazol-2-yl)Quinoxaline Derivatives as Potent Anticancer Compounds: Privileged Structure-Based Design, Synthesis, and Bioactive Evaluation In Vitro and In Vivo,” European Journal of Medicinal Chemistry 165 (2019): 293–308. doi:10.1016/j.ejmech.2019.01.004
   PubMed Web of Science ®Google Scholar
• C. Patinote, C. Deleuze-Masquefa, K. Hadj Kaddour, L. Vincent, R. Larive, Z. Zghaib, J. Guichou, M. Assaf, P. Cuq, and P. Bonnet, “Imidazo[1,2-a]Quinoxalines for Melanoma Treatment with Original Mechanism of Action,” European Journal of Medicinal Chemistry 212 (2021): 113031.
   PubMed Web of Science ®Google Scholar
• Zhongrui Chen, Maxime Bert, Simon Pascal, Gabriel Canard, and Olivier Siri, “Versatile Transamination in Quinonediimine Chemistry: Towards a Novel Class of Water Soluble UV/Violet Chromophores,” Tetrahedron Letters 60, no. 38 (2019): 151024. doi:10.1016/j.tetlet.2019.151024
   Web of Science ®Google Scholar
• A. Gupta, M. S. Deshmuk, and N. Jain, “Iodine-Catalyzed C–N Bond Formation: Synthesis of 3-Aminoquinoxalinones under Ambient Conditions,” The Journal of Organic Chemistry 82, no. 9 (2017): 4784–92. doi:10.1021/acs.joc.7b00464
   PubMed Web of Science ®Google Scholar
• X. Sun, W. Wang, Y. Li, J. Ma, and S. Yu, “Halogen-Bond-Promoted Double Radical Isocyanide Insertion under Visible-Light Irradiation: Synthesis of 2-Fluoroalkylated Quinoxalines,” Organic Letters 18, no. 18 (2016): 4638–41.
   PubMed Web of Science ®Google Scholar
• S. Shee, K. Ganguli, K. Jana, and S. Kundu, “Cobalt Complex Catalyzed Atom-Economical Synthesis of Quinoxaline, Quinoline and 2-Alkylaminoquinoline Derivatives,” Chemical Communications 54, no. 50 (2018): 6883–6.
   PubMed Web of Science ®Google Scholar
• A. Mondal, M. K. Sahoo, M. Subaramanian, and E. Balaraman, “Manganese(I)-Catalyzed Sustainable Synthesis of Quinoxaline and Quinazoline Derivatives with the Liberation of Dihydrogen,” The Journal of Organic Chemistry 85, no. 11 (2020): 7181–91.
   PubMed Web of Science ®Google Scholar
• S. Shee, D. Panja, and S. Kundu, “Nickel-Catalyzed Direct Synthesis of Quinoxalines from 2-Nitroanilines and Vicinal Diols: Identifying Nature of the Active Catalyst,” The Journal of Organic Chemistry 85, no. 4 (2020): 2775–84.
   PubMed Web of Science ®Google Scholar
• M. Imanishi, M. Sonoda, H. Miyazato, K. Sugimoto, M. Akagawa, and S. Tanimori, “Sequential Synthesis, Olfactory Properties, and Biological Activity of Quinoxaline Derivatives,” ACS Omega 2, no. 5 (2017): 1875–85. doi:10.1021/acsomega.7b00124
   PubMed Web of Science ®Google Scholar
• J. Guillon, E. Mouray, S. Moreau, C. Mullie, I. Forfar, V. Desplat, S. Belisle-Fabre, N. Pinaud, F. Ravanello, A. Le-Naour, et al, “New Ferrocenic Pyrrolo[1,2-a]Quinoxaline Derivatives: synthesis, and In Vitro Antimalarial activity-Part II,” European Journal of Medicinal Chemistry 46, no. 6 (2011): 2310–26. doi:10.1016/j.ejmech.2011.03.014
   PubMed Web of Science ®Google Scholar
• M. Hajri, M. Esteve, O. Khoumeri, R. Abderrahim, T. Terme, M. Montana, and P. Vanelle, “Synthesis and Evaluation of In Vitro Antiproliferative Activity of New Ethyl 3-(Arylethynyl)Quinoxaline-2-Carboxylate and Pyrido[4,3-b]Quinoxalin-1(2H)-One Derivatives,” European Journal of Medicinal Chemistry 124 (2016): 959–66.
   PubMed Web of Science ®Google Scholar
• M. S. F. Franco, M. H. Paula, P. C. Glowacka, F. Fumagalli, G. C. Clososki, and F. S. Emery, “Palladium-Catalyzed C–H Alkenylation of Quinoxaline N-Oxide Enabled by a Mono-N-Protected Amino Acid,” Tetrahedron Letters 59, no. 26 (2018): 2562–6. doi:10.1016/j.tetlet.2018.05.054
   Web of Science ®Google Scholar
• K. Danoun, Y. Essamlali, O. Amadine, H. Mahi, and M. Zahouily, “Eco-Friendly Approach to Access of Quinoxaline Derivatives Using Nanostructured Pyrophosphate Na2PdP2O7 as a New, Efficient and Reusable Heterogeneous Catalyst,” BMC Chemistry 14, no. 1 (2020): 6. doi:10.1186/s13065-020-0662-z
   PubMed Web of Science ®Google Scholar
• Chenna Krishna Reddy. Reddivari, Subba Rao Devineni, Bakthavatchala Reddy Nemallapudi, Gundala Sravya, Balakrishna Avula, Nayabrasool Shaik, Vishnu Nayak Badavath, Grigory V. Zyryanov, Rami Reddy Yellala Venkata, and Naga Raju Chamarthi, “Design, Synthesis, Biological Evaluation and Molecular Docking Studies of 1,4-Disubstituted 1,2,3-Triazoles: PEG-400:H2O Mediated Click Reaction of Fluorescent Organic Probes under Ultrasonic Irradiation,” Polycyclic Aromatic Compounds 42, no. 7 (2022): 3953–74. doi:10.1080/10406638.2021.1878246
   Web of Science ®Google Scholar
• Bakthavatchala Reddy Nemallapudi, Grigory V. Zyryanov, Balakrishna Avula, Mallikarjuna Reddy Guda, Suresh Reddy Cirandur, Chintha Venkataramaiah, Wudayagiri Rajendra, and Sravya Gundala, “Meglumine as a Green, Efficient and Reusable Catalyst for Synthesis and Molecular Docking Studies of Bis(Indolyl)Methanes as Antioxidant Agents,” Bioorganic Chemistry 87 (2019): 465–73. doi:10.1016/j.bioorg.2019.03.005
   PubMed Web of Science ®Google Scholar
• F. Li, X. Tang, Y. Xu, C. Wang, Z. Wang, Z. Li, and L. Wang, “A Dual-Protein Cascade Reaction for the Regioselective Synthesis of Quinoxalines,” Organic Letters 22, no. 10 (2020): 3900–4.
   PubMed Web of Science ®Google Scholar
• C. Lee, W. Wu, P. S. Dangate, L. Shen, W. Chung, and C. Sun, “Skeletally Diverse Synthesis of Innovative [2,1-c]-1,4-Oxazepine and [1,4]-Quinoxaline Systems,” ACS Combinatorial Science 17, no. 10 (2015): 623–30.
   PubMed Web of Science ®Google Scholar
• A. Rashidizadeh, H. Ghafuri, H. R. E. Zand, and N. Goodarzi, “Graphitic Carbon Nitride Nanosheets Covalently Functionalized with Biocompatible Vitamin B1: Synthesis, Characterization, and Its Superior Performance for Synthesis of Quinoxalines,” ACS Omega 4, no. 7 (2019): 12544–54.
   PubMed Web of Science ®Google Scholar
• Shaik Shahinshavali, Kazi Amirul Hossain, Abbaraju Venkata Durga Nagendra Kumar, Alugubelli Gopi Reddy, Deepti Kolli, Ali Nakhi, Mandava Venkata Basaveswara Rao, and Manojit Pal, “Ultrasound Assisted Synthesis of 3-Alkynyl Substituted 2-Chloroquinoxaline Derivatives: Their In Silico Assessment as Potential Ligands for N-Protein of SARS-CoV-2,” Tetrahedron Letters 61, no. 40 (2020): 152336.
   PubMed Web of Science ®Google Scholar
• E. Vijaya Ragavan and J. H. Hansen, "A Green, Scalable, and Catalyst-Free One-Minute Synthesis of Quinoxalines," SynOpen 5 (2021): 43–8.
   Google Scholar
• X. K. He, J. Lu, A. J. Zhang, Q. Q. Zhang, G. Y. Xu, and J. Xuan, “BI-OAc-Accelerated C3-H Alkylation of Quinoxalin-2(1H)-Ones under Visible-Light Irradiation,” Organic Letters 22, no. 15 (2020): 5984–9. doi:10.1021/acs.orglett.0c02080
   PubMed Web of Science ®Google Scholar
• L. Liao, M. Song, J. Feng, M. Tan, F. Liu, Z. Qiu, S. Zhang, and B. Li, “Green Synthesis of Indeno[1,2-b]Quinoxalines Using β-Cyclodextrin as Catalyst,” Molecules 27, no. 2 (2022): 580. doi:10.3390/molecules27020580
   PubMed Web of Science ®Google Scholar
• A. Laventure, C. R. Harding, C. Edward, Z. Li, J. Wang, Y. Zou, and G. C. Welch, “Screening Quinoxaline-Type Donor Polymers for Roll-to-Roll Processing Compatible Organic Photovoltaics,” ACS Applied Polymer Materials 1, no. 8 (2019): 2168–76. doi:10.1021/acsapm.9b00433
   Web of Science ®Google Scholar
• S. A. Galal, A. S. Abdelsamie, S. M. Soliman, J. Mortier, G. Wolber, M. M. Ali, H. Tokuda, N. Suzuki, A. Lida, R. A. Ramadan, et al, “Design, Synthesis and Structureeactivity Relationship of Novel Quinoxaline Derivatives as Cancer Chemopreventive Agent by Inhibition of Tyrosine Kinase Receptor,” European Journal of Medicinal Chemistry 69 (2013): 115–24.
   PubMed Web of Science ®Google Scholar
• A. L. Bagdasarian, H. H. Nguyen, T. A. Palazzo, J. C. Fettinger, M. J. Haddadin, and M. J. Kurth, “One-Pot Synthesis of Benzo[4,5]Imidazo[2,1-a]Isoquinolines and Isoquinolino[3,4-b]Quinoxalines via Tandem Cyclization Strategies,” The Journal of Organic Chemistry 81, no. 9 (2016): 3924–8.
   PubMed Web of Science ®Google Scholar
• A. Carta, G. Sanna, I. Briguglio, S. Madeddu, G. Vitale, S. Piras, P. Corona, A. T. Peana, E. Laurini, F. Maurizio, S. Pricl, et al, “Quinoxaline Derivatives as New Inhibitors of Coxsackievirus B5,” European Journal of Medicinal Chemistry 145 (2018): 559–69.
   PubMed Web of Science ®Google Scholar
• M. K. Ibrahim, M. S. Taghour, A. M. Metwaly, A. Belal, A. B. M. Mehany, M. A. Elhendawy, M. M. Radwan, A. M. Yassin, N. M. El-Deeb, E. E. Hafez, et al, “Design, Synthesis, Molecular Modeling and Anti-Proliferative Evaluation of Novel Quinoxaline Derivatives as Potential DNA Intercalators and Topoisomerase II Inhibitors,” European Journal of Medicinal Chemistry 155 (2018): 117–34.
   PubMed Web of Science ®Google Scholar
• L. Bonilla-Ramirez, A. Rios, M. Quiliano, G. Ramirez-Calderon, I. Beltran-Hortelano, J. François Franetich, L. Corcuera, M. Bordessoulles, A. Vettorazzi, A. Lopez de Cerain, et al, “Novel Antimalarial Chloroquine- and Primaquine-Quinoxaline 1,4-Di-N-Oxide Hybrids: Design, Synthesis, Plasmodium Life Cycle Stage Profile, and Preliminary Toxicity Studies,” European Journal of Medicinal Chemistry 158 (2018): 68–81. doi:10.1016/j.ejmech.2018.08.063
   PubMed Web of Science ®Google Scholar
• Q. Guan, L. Cong, Q. Wang, C. Yu, K. Bao, K. Zhou, L. Wu, and W. Zhang, “Activated Carbon/Brønsted Acid-Promoted Aerobic Benzylic Oxidation under “On-Water” Condition: Green and Efficient Synthesis of 3-Benzoylquinoxalinones as Potent Tubulin Inhibitors,” European Journal of Medicinal Chemistry 186 (2020): 111894.
   PubMed Web of Science ®Google Scholar
• V. A. Kuehl, P. H. H. Duong, D. Sadrieva, S. A. Amin, Y. She, K. D. Li-Oakey, J. L. Yarger, B. A. Parkinson, and J. O. Hoberg, “Synthesis, Postsynthetic Modifications, and Applications of the First Quinoxaline-Based Covalent Organic Framework,” ACS Applied Materials & Interfaces 13, no. 31 (2021): 37494–9. doi:10.1021/acsami.1c08854
   PubMed Web of Science ®Google Scholar
• L. Fabian, M. T. Porro, N. Gomez, M. Salvatori, G. Turk, D. Estrin, and A. Moglioni, “Design, Synthesis and Biological Evaluation of Quinoxaline Compounds as Anti-HIV Agents Targeting Reverse Transcriptase Enzyme,” European Journal of Medicinal Chemistry 188 (2020): 111987.
   PubMed Web of Science ®Google Scholar
• S. Satish, S. Singh, M. Jayapal Reddy, Y. A. Sonawane, J. V. Napoleon, S. Rana, J. I. Contreras, C. Rajesh, E. L. Ezell, S. Kizhake, et al, “Structure Activity Relationship (SAR) Study Identifies a Quinoxaline Urea Analog That Modulates IKKb Phosphorylation for Pancreatic Cancer Therapy,” European Journal of Medicinal Chemistry 222 (2021): 113579.
   PubMed Web of Science ®Google Scholar
• H. Zhang, Q. Lu, J. Zhang, W. Qu, S. Xie, L. Huang, Z. Yuan, and Y. Pan, “Discovery of Novel Nitrogenous Heterocyclic-Containing Quinoxaline-1,4-Di-N-Oxides as Potent Activator of Autophagy in M.tb-Infected Macrophages,” European Journal of Medicinal Chemistry 223 (2021): 113657.
   PubMed Web of Science ®Google Scholar
• K. Saravana Mani, B. Murugesapandian, Kaminsky Werner, and P. Rajendran Subramaniam, “Enantioselective Approach towards the Synthesis of Spiro-Indeno [1,2-b] Quinoxaline Pyrrolothiazoles as Antioxidant and Antiproliferative,” Tetrahedron Letters 59, no. 30 (2018): 2921–9. doi:10.1016/j.tetlet.2018.06.035
   Web of Science ®Google Scholar